As of 2026-09-30, the Relative Valuation of Akoya Biosciences Inc (AKYA) is (30.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.29 USD, the upside of Akoya Biosciences Inc based on Relative Valuation is -2460.6%.
The range of the Relative Valuation is (32.64) - (29.94) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 34.3x - 35.9x | 34.3x |
| Forward P/E multiples | 26.6x - 31.5x | 29.7x |
| Fair Price | (32.64) - (29.94) | (30.45) |
| Upside | -2630.3% - -2420.8% | -2460.6% |
| Date | P/E |